This Id2-CreERT2 knock-in allele was designed to both abolish Id2 gene function and direct CreERT2 fusion protein expression from the endogenous Id2 promoter/enhancer elements. Cre-ERT2 fusion gene activity is inducible by tamoxifen administration.
Yuan Zhuang, Duke University Medical Center
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Recombinase-expressing, Inducible) | Id2 | inhibitor of DNA binding 2 |
The Id2-CreERT2 knockin allele was designed to both abolish inhibitor of DNA binding 2 (Id2) gene function and express CreERT2 fusion protein from the Id2 promoter/enhancer elements. Cre-ERT2 fusion gene activity is inducible and can be observed following tamoxifen administration. As such, when Id2-CreERT2 knockin mice are bred with mice containing loxP-flanked sequences, tamoxifen-inducible Cre-mediated recombination will result in deletion of the floxed sequences in the Id2-expressing cells of the offspring.
No mRNA or protein expression from the Id2-CreERT2 allele is observed. The donating investigator reports that homozygous mice are runted with defective lung alveolarization. Other organ systems have not been evaluated. However, Id2-CreERT2 homozygotes may be expected to exhibit the same phenotype as mice homozygous for other null mutations of this gene (including postnatal lethality and defects of the immune system, digestive tract, kidneys, adipose tissue and mammary gland development).Heterozygous mice are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. The donating investigator also reports tamoxifen-inducible Cre recombinase activity recapitulates the endogenous Id2 expression pattern. Following tamoxifen administration, Cre recombinase activity recapitulates the epithelial expression of the endogenous gene (distal tip lung epithelial multipotent precursor cells of the developing lung throughout branching morphogenesis up to embryonic day (E)16.5). Additionally, the Cre recombinase activity in immune cells (during lymphopoiesis, hematopoiesis, or adaptive immune responses) was not directly assessed by the donating investigator. Cre recombinase activity is not observed in lung tissue prior to tamoxifen treatment(other systems not examined).
Of note, the same group designed an identically-targeted Id2-eGFP knockin mouse line to express an enhanced green fluorescent protein (rather than Cre-ERT2 fusion protein) from the Id2 promoter/enhancer elements. That Id2-eGFP knockin mouse line is available as Stock No. 016224.
The Cre-ERT2 fusion protein consists of Cre recombinase fused to a triple mutant form of the human estrogen receptor which does not bind its natural ligand (17β-estradiol) at physiological concentrations but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, Cre-ERT2 can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered.
The Id2-CreERT2 knockin mutation was created by the laboratory of Dr. Brigid LM Hogan (Duke University Medical Center). A targeting vector was designed to insert a CreERT2 fusion gene (followed by an frt-flanked PGK-neo cassette) into the translation initiation codon of the inhibitor of DNA binding 2 locus (Id2); replacing most of exon 1 except the final 25 nucleotides. The CreERT2 fusion gene (Cre-ERT2) is Cre recombinase fused to a G400V/M543A/L544A triple mutation of the human estrogen receptor ligand binding domain. The targeting construct was electroporated into 129SvEv-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts and chimeric mice were bred with C57BL/6NCrl mice to originate the colony. Mutant mice were bred with ROSA26-FLPe mice (on an uncharacterized genetic background) to remove the PGK-neo selection cassette. These Id2-CreERT2 knockin mice were subsequently bred to C57BL/6NCrl mice for 5-8 generations (and the ROSA26-FLPe was removed). Next, heterozygous mutant mice were sent to Dr. Yuan Zhang (Duke University) where they were backcrossed to C57BL/6J mice (see SNP note below) for at least one additional generation prior to sending to The Jackson Laboratory Repository. Upon arrival, Id2-CreERT2 knockin mice were bred with C57BL/6NJ inbred mice (Stock No. 005304) for at least one generation to establish the Id2-CreERT2 knockin colony. During backcrossing, the donating investigator reports that the Y chromosome was fixed to the C57BL/6J genetic background.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 4 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
---|---|
Site of Expression | Following tamoxifen administration, Cre recombinase activity recapitulates the epithelial expression of the endogenous gene (distal tip lung epithelial multipotent precursor cells of the developing lung throughout branching morphogenesis up to embryonic day (E)16.5). |
Allele Name | targeted mutation 1.1, Brigid L Hogan |
---|---|
Allele Type | Targeted (Recombinase-expressing, Inducible) |
Allele Synonym(s) | Id2tm1(CRE/ESR1)Blh; Id2-CreERT2 |
Gene Symbol and Name | Id2, inhibitor of DNA binding 2 |
Gene Synonym(s) | |
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
Site of Expression | Following tamoxifen administration, Cre recombinase activity recapitulates the epithelial expression of the endogenous gene (distal tip lung epithelial multipotent precursor cells of the developing lung throughout branching morphogenesis up to embryonic day (E)16.5). |
Strain of Origin | 129S/SvEv |
Chromosome | 12 |
Molecular Note | The targeting vector contained an cre/ERT2 cassette inserted at the translation initiation codon of the Id2 locus, replacing most of exon 1, except for the final 25 nucleotides. The cre cassette was followed by a frt-PGK-neo-frt cassette, which was removed by flp-mediated excision after germline transmission. |
Mutations Made By | Brigid Hogan, Duke University Medical Center |
When maintaining a live colony, heterozygous mice may be bred together, to wildtype siblings or to C57BL/6NJ inbred mice (Stock No. 005304). Breeding homozygous mice on a C57BL/6 genetic background together may be expected to result in perinatal lethality with nearly full penetrance. This perinatal lethality is significantly diminished if maintaining homozygous mice on a mixed genetic background.
When using the Id2-CreERT2 mouse strain in a publication, please cite the originating article(s) and include JAX stock #016222 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Id2<tm1.1(cre/ERT2)Blh> |
Frozen Mouse Embryo | B6.129S(Cg)-Id2<tm1.1(cre/ERT2)Blh>/ZhuJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129S(Cg)-Id2<tm1.1(cre/ERT2)Blh>/ZhuJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129S(Cg)-Id2<tm1.1(cre/ERT2)Blh>/ZhuJ Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.129S(Cg)-Id2<tm1.1(cre/ERT2)Blh>/ZhuJ Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.